← Leaderboards
Athena F Zuppa
Childrens Hospital Of Philadelphia
$6,631,501
Attributed
$8,930,587
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,930,587 · 11
By mechanism
R01$5,497,655 · 3
UG1$1,733,760 · 1
K23$661,800 · 1
R21$505,523 · 1
PL1$467,015 · 2
M01$64,834 · 3
Top collaborators
- Robert Allen Berg6 shared
- Mark W Hall3 shared
- Martha Aq Curley2 shared
- Sapna R Kudchadkar2 shared
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodChildBaseFunctional DisorderDesignProgramsClinical TrialsOrganDosePharmacologyCaringCritical IllnessCritically Ill ChildrenMorbidity - Disease RatePharmaceutical PreparationsFutureClinical ResearchFundingPediatric ResearchExpectationPerformanceIntensive CareCritical CareInnovation
Grant awards (32)
Collaborative Pediatric Critical Care Research Network - Clinical Site$99,697
PL1 · FY2025 · HD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$94,973
PL1 · FY2024 · HD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$89,770
PL1 · FY2023 · HD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$89,773
PL1 · FY2022 · HD · contact PI
PediAtric ReseArch of Drugs, Immunoparalysis and Genetics during MODS (PARADIGM)$636,392
R01 · FY2021 · HD
Collaborative Pediatric Critical Care Research Network - Clinical Site$92,802
PL1 · FY2021 · HD · contact PI
PediAtric ReseArch of Drugs, Immunoparalysis and Genetics during MODS (PARADIGM)$753,684
R01 · FY2020 · HD
Pediatric Critical Care Research Network at Children's Hospital of Philadelphia$288,960
UG1 · FY2020 · HD
PediAtric ReseArch of Drugs, Immunoparalysis and Genetics during MODS (PARADIGM)$800,305
R01 · FY2019 · HD
Pediatric Critical Care Research Network at Children's Hospital of Philadelphia$288,960
UG1 · FY2019 · HD
Pediatric Critical Care Research Network at Children's Hospital of Philadelphia$288,960
UG1 · FY2018 · HD
RESTORE resilience in critically ill children - R2$210,234
R21 · FY2018 · HD
RESTORE resilience in critically ill children - R2$295,289
R21 · FY2017 · HD
Pediatric Critical Care Research Network at Children's Hospital of Philadelphia$288,960
UG1 · FY2017 · HD
Pediatric Critical Care Research Network at Children's Hospital of Philadelphia$288,960
UG1 · FY2016 · HD
Impact of Hypothermia on Midazolam and Morphine Pharmacokinetics$411,797
R01 · FY2015 · HL · contact PI
Pediatric Critical Care Research Network at Children's Hospital of Philadelphia$288,960
UG1 · FY2015 · HD
Impact of Hypothermia on Midazolam and Morphine Pharmacokinetics$408,755
R01 · FY2014 · HL · contact PI
Impact of Hypothermia on Midazolam and Morphine Pharmacokinetics$400,215
R01 · FY2013 · HL · contact PI
Impact of Hypothermia on Midazolam and Morphine Pharmacokinetics$430,818
R01 · FY2012 · HL · contact PI
Impact of Pharmacology on Duration of Ventilation in Patients with Resp Failure$409,838
R01 · FY2012 · HL · contact PI
Impact of Pharmacology on Duration of Ventilation in Patients with Resp Failure$409,868
R01 · FY2011 · HL · contact PI
Impact of Pharmacology on Duration of Ventilation in Patients with Resp Failure$414,040
R01 · FY2010 · HL · contact PI
Impact of Pharmacology on Duration of Ventilation in Patients with Resp Failure$421,943
R01 · FY2009 · HL · contact PI
Improving Drug Development for the Critically Ill Child$132,472
K23 · FY2009 · HD · contact PI
Improving Drug Development for the Critically Ill Child$132,472
K23 · FY2008 · HD · contact PI
Improving Drug Development for the Critically Ill Child$132,472
K23 · FY2007 · HD · contact PI
Improving Drug Development for the Critically Ill Child$132,472
K23 · FY2006 · HD · contact PI
Improving Drug Development for the Critically Ill Child$131,912
K23 · FY2005 · HD
A PHARMACOKINETIC STUDY OF DEXMEDETOMIDINE IN INFANTS$60,958
M01 · FY2005 · RR
PHARMACOKINETIC PROPERTIES OF TRANSDERMAL CLONIDINE IN CRITICALLY ILL CHILDREN$258
M01 · FY2005 · RR
Ped PK study of CSF penetration of one dose IV Synercid$3,618
M01 · FY2004 · RR